Modern Healthcare Technology Issues FY2025/26 ESG Report – Scope-2 Emissions Fall 12.5%, Water Use Down 16.9%, New Targets Set for FY2026/27

Bulletin Express
07/27

Modern Healthcare Technology released its Environmental, Social and Governance (ESG) Report for the year ended 31 March 2026, covering 46 “be Beauty Shop” points of sale and service centres in Hong Kong and Singapore.

The report shows a 9.50% year-on-year reduction in total greenhouse-gas (GHG) emissions to 1,784.68 tonnes of CO₂-equivalent. Scope-2 (energy-indirect) emissions, which account for 94.93% of the Group’s total, dropped 12.50% to 1,694.12 tonnes, while Scope-1 (direct) emissions rose to 80.41 tonnes after the inclusion of refrigerant leakage data. Scope-3 (other indirect) emissions were broadly unchanged at 10.15 tonnes.

Electricity consumption was largely flat at 3.54 million kWh (+0.60%), but overall energy use edged up 0.90% to 3.64 million kWh after higher diesel demand. Water consumption declined 16.90% to 17,941.91 m³, and non-hazardous packaging waste fell to 14.46 tonnes from 17.04 tonnes.

Operational targets for FY2026/27 are to keep the intensity of air emissions, GHG emissions, town-gas use, electricity use, water consumption, wastewater discharge and non-hazardous waste at FY2025/26 levels. The Group also aims to switch 50% of its packaging to recycled paper by 2030.

Governance of ESG matters rests with the Board, which integrates the United Nations Sustainable Development Goals into strategy. Material focus areas are employee management, product responsibility, and business ethics and compliance. Supply-chain oversight covers 125 suppliers—45 in Hong Kong, 68 in mainland China and 12 elsewhere—with 100% subject to the Group’s engagement and assessment procedures.

Climate-related disclosures have been expanded in line with IFRS S2. Key physical and transition risks include extreme weather and tightening regulations; opportunities cited involve growing demand for sustainable products and lower long-term energy costs. Quantitative scenario analysis and Scope-3 expansion are in development.

Social indicators show a workforce of 780 employees, turnover of 21.5%, zero fatalities, four work-related injuries (444 lost days) and 18,369.5 training hours delivered to 611 employees. No product recalls, privacy breaches or concluded corruption cases were reported during the year, and the Group maintained compliance with all relevant environmental and labour regulations.

Management reiterates that ESG considerations are embedded in decision-making processes to support sustainable growth across its health and beauty operations.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10